These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15073652)

  • 1. Eggplant (Solanum melongena) extract does not alter serum lipid levels.
    Praça JM; Thomaz A; Caramelli B
    Arq Bras Cardiol; 2004 Mar; 82(3):269-76. PubMed ID: 15073652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR; Tandon M; Sharma PL
    Int J Clin Pract; 2007 Nov; 61(11):1812-8. PubMed ID: 17935545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects.
    Cesar TB; Aptekmann NP; Araujo MP; Vinagre CC; Maranhão RC
    Nutr Res; 2010 Oct; 30(10):689-94. PubMed ID: 21056284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lowering of the plasma lipid concentration with lovastatin. A clinical study in patients with primary hypercholesterolemia].
    Grüneberger S; Dreyer M; Kangah R; Reinicke A; Staisch C; Steinhagen-Thiessen E; Müller P; Simon B; Dammann HG
    Dtsch Med Wochenschr; 1989 Nov; 114(45):1734-9. PubMed ID: 2806106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasma antioxidant potential in dyslipidemic subjects.
    Bertipaglia de Santana M; Mandarino MG; Cardoso JR; Dichi I; Dichi JB; Camargo AE; Fabris BA; Rodrigues RJ; Fatel EC; Nixdorf SL; Simão AN; Cecchini R; Barbosa DS
    Nutrition; 2008 Jun; 24(6):562-8. PubMed ID: 18455656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols.
    Korpela R; Tuomilehto J; Högström P; Seppo L; Piironen V; Salo-Väänänen P; Toivo J; Lamberg-Allardt C; Kärkkäinen M; Outila T; Sundvall J; Vilkkilä S; Tikkanen MJ
    Eur J Clin Nutr; 2006 May; 60(5):633-42. PubMed ID: 16404415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
    Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J; Hoffman R; Hanson M; Veltri E
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of some medicinal plants on plasma antioxidant system and lipid levels in rats.
    Choi EM; Hwang JK
    Phytother Res; 2005 May; 19(5):382-6. PubMed ID: 16106392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
    Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.